The role of brain developmental abnormalities in the pathogenesis of schizophrenia

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 110, Issue 2, 2010, Pages 97-101

  Khoyetsyan, A G ^a   Boyajyan, A S ^a  

^a NONE

Author keywords

Aberrant apoptosis; Neurodevelopmental theory; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DYSBINDIN;

APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN MALFORMATION; HUMAN; SCHIZOPHRENIA;

EID: 78650574621     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Akbarian S., Kim J. J., Potkin S. G. et al. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch General Psychiat 1996;53:425-436.
2. Arnold S. E., Talbot K., Hahn C. G. Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Prog Brain Res 2005;147:319-345.
3. Beasley C., Cotter D., Khan N. et al. Glycogen synthase kinase-3 beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. Neurosci Lett 2001;302:117-120.
4. Benson M. A., Newey S. E., Martin-Rendon E. et al. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 2001;276:24232-24241.
5. Berger G. E., Wood S., McGorry P. D. Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacol Bull 2003;37:79-101.
6. Blackwood D. H., Fordyce A., Walker M. T. et al. Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001;69:428-433.
7. Boatright K. M., Salvesen G. S. Mechanisms of caspase activation. Curr Opin Cell Biol 2003;15:725-731.
8. Bredesen D. E. Neural apoptosis. Ann Neurol 1995;38:839-851.
9. Brown A. S., Begg M. D., Gravenstein S. et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiat 2004;61:774-780.
10. Brzustowicz L. M., Hodgkinson K. A., Chow E. C. et al. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000;288:678-82.
11. Buka S. L., Tsuang M. T., Torrey E. F. et al. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiat 2001;58:1032-1037.
12. Cannon M., Jones P. Schizophrenia. J Neurol Neurosurg Psychiat 1996;60:604-613.
13. Cannon M., Jones P. B., Murray R. M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiat 2002;159:1080-1092.
14. Catts V. S., Catts S. V. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res 2000;41:405-415.
15. Catts V. S., Catts S. V., McGrath J. J. et al. Apoptosis and schizophrenia: A pilot study based on dermal fibroblast cell lines. Schizophr Res 2006;84:20-28.
16. Chana G., Landau S., Beasley C. et al. Two-dimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiat 2003;53:1086-1098.
17. Coyle J. T. The GABA-glutamate connection in schizophrenia: which is the proximate cause? Bioch Pharmacol 2004;68:1507-1514.
18. Davidson M., Reichenberg A., Rabinowitz J. et al. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiat 1999;156:1328-1335.
19. Di Forti M., Lappin J. M., Murray R. M. Risk factors for schizophrenia-All roads lead to dopamine. Eur Neuropsychopharmacol 2007;17: S101-S107.
20. Done D. J., Crow T. J., Johnstone E. C., Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. Br Med J 1994;309:699-703.
21. Eagles J. M. Are poliviruses a cause of schizophrenia? Br J Psychiat 1992;160:598-600.
22. Eastwood S. L., Law A. J., Everall I. P., Harrison P. J. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiat 2003;8:148-155.
23. Ebert T., Kotler M. Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. IMAJ 2005;7:35-38.
24. Egan M. F., Goldberg T. E., Kolachana B. S. et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001;98:6917-6922.
25. Fish B., Marcus J., Hans S. L. et al. Infants at risk for schizophrenia: sequelae of a genetic neurointe-grative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiat 1992;49:221-235.
26. Friedlander R. M. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003;348:1365-1375.
27. Geddes J. R., Lawrie S. M. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiat 1995;167:786-793.
28. Gilmore J. H., Jarskog L. F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 1997;24:365-367.
29. Glantz L. A., Gilmore J. H., Lieberman J. A., Jarskog L. F. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 2006;81:47-63.
30. Harrison P. J., Weinberger D. R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiat 2005;10:40-68.
31. Hodgkinson C. A., Goldman D., Jaeger J. et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004;75:862-872.
32. Hultman C. M., Ohman A., Cnattingius S. et al. Prenatal and neonatal risk factors for schizophrenia. Br J Psychiat 1997;170:128-133.
33. Innocenti G. M., Ansermet F., Parnas J. Schizophrenia, neurodevelopment and corpus callosum. Mol Psychiat 2003;8:261-274.
34. Jarskog L. F., Glantz L. A., Gilmore J. H., Lieberman J. A. Apoptotic mechanisms in the pathophysiology of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2005;29:846-858.
35. Jarskog L. F., Selinger E. S., Lieberman J. A., Gilmore J. H. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiat 2004;161:1: 109-115.
36. Konradi C., Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 2003;97:153-179.
37. Kozlovsky N., Belmaker R. H., Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol 2002;12:13-25.
38. Lang U. E., Puls I., Muller D. J. et al. Molecular Mechanisms of Schizophrenia. Cell Physiol Biochem 2007;20:687-702.
39. Lewis D. A., Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat Med 2006;12:1016-1022.
40. Lewis D. A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002;25:409-432.
41. Li D., Collier D. A., He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 2006;15:1995-2002.
42. Mackie S., Millar J. K., Porteous D. J. Role of DISC1 in neural development and schizophrenia. Current Opinion in Neurobiology 2007;17:95-102.
43. McNeil T. F., Cantor-Graae E., Ismail B. Obstetric complications and congenital malformation in schizophrenia. Brain Res Rev 2000;31:166-78.
44. Mednick S. A., Machon R. A., Huttunen M. O., Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiat 1988;45:189-192.
45. Müller N., Schwarz M. J. Schizophrenia as an inflammation-mediated dysbalanse of glutamatergic neurotransmission. Neurotoxicity Res 2006;10:2: 131-148.
46. Murray R. M., O'Callaghan E., Castle D. J., Lewis S. W. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 1992;18:319-332.
47. Olin S. S., Mednick S. A. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophr Bull 1996;22:223-240.
48. Pearce B. D. Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms. Mol Psychiat 2001;6:634-646.
49. Pulver A. E. Search for schizophrenia susceptibility genes. Biol Psychiat 2000;47:221-230.
50. Rantakallio P., Jones P., Moring J., Von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 1997;26:837-843.
51. Rapoport J. L., Addington A. M., Frangou S., Ppsych M. C. The neurodevelopmental model of schizophrenia. Mol Psychiat 2005;10:434-444.
52. Rothermundt M., Arolt V., Bayer T. A. Review of immunological and immunophatological findings in schizophrenia. Brain Behav Immun 2001;15:4: 319-339.
53. Schwab S. G., Knapp M., Mondabon S. et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sibpair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003;72:185-190.
54. Stefansson H., Thorgeirsson T. E., Gulcher J. R., Stefansson K. Neuregulin 1 in schizophrenia: out of Iceland. Mol Psychiat 2002;8:639-640.
55. Strous R. D., Shoenfeld Y. Revisiting old ghosts: Prenatal viral exposure and schizophrenia. IMAJ 2005;7:43-35.
56. Strous R. D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited. J Autoimmun 2006;27:71-80.
57. Talbot K., Arnold S. E. The parahippocampal region in schizophrenia. In: The Parahippocampal region, organization and role in cognitive functions. Oxford: Oxford University Press 2002;295-318.
58. Terenius L. Schizophrenia: pathophysiological mechanisms - a synthesis. Brain Res Rev 2000;31:401-404.
59. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
60. Waterworth D. M., Basset A. S., Brzustowitctz L. M. Recent advances in the genetics of schizophrenia. Cell Mol Life Sci 2002;59:331-348.
61. Weinberger D. R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiat 1987;44:660-669.
62. Wong A. C., Van Tol H. M. Schizophrenia: from phenomenology to neurobiology. Neuroscience and Biobehavioral Rev 2003;27:269-306.
63. Yolken R. H., Karlsson H., Yee F. et al. Endogenous retroviruses and schizophrenia. Brain Res Rev 2000;31:193-199.
64. Yolken R. H., Torrey E. F. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995;8:131-145.